Presentation TVT 2020 SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes Presenter: Susheel K. Kodali June 21, 2020
Presentation TVT 2017 After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients? Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani June 16, 2017
Presentation TVT 2016 Highlights From PARTNER 2A in Intermediate-Risk Patients Presenter: Michael J. Mack June 16, 2016
Presentation TCT 2014 Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Vinod H. Thourani September 13, 2014
Presentation TCT 2013 Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies Presenter: Jodi Akin October 30, 2013
Presentation TCT 2013 Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A Presenter: Martin Leon October 27, 2013
Presentation TCT 2012 Update from the Randomized PARTNER 2A Trial Presenter: Martin Leon October 22, 2012